NovaBay Pharmaceuticals, Inc.

Industry

  • Pharmaceuticals
    • OTC, Consumer
    • Vaccines
    • Drug Delivery
      • Topical Delivery
      • Site Specific
    • Specialty Pharmaceuticals
  • Digital Health
    • Disease Management
  • Biotechnology

Other Names/Subsidiaries

  • NovaCal Pharmaceuticals
See more in Biomedtracker

Latest on NovaBay Pharmaceuticals, Inc.

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip

Sanpower Reconstructs Dendreon Deal To Drive Better Growth

 
• By Ying Huang

Five months after completing the acquisition of Dendreon Corp. , Chinese conglomerate Sanpower Group has taken a substantial step toward making real progress with the heart of the deal, Provenge

In Vivo

Execs On The Move, August 2017

 
• By Regina Paleski

Company Changes ADENT , John To: Neogen Corp. , CEO (July) From: Animal Health International, CEO Phone: 517-372-9200 ARENA , Paul To: Parallax Health Sciences Inc. , CEO (July) From: Arena

In Vivo

Deals Shaping the Medical Industry, September 2016

 
• By Beth Allan, Steven Muntner, Maureen Riordan, and Deanna Kamienski

IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Corp. Advanced Cell Diagnostics Inc. Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Dia